Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialHuman Geneticsen_US
dc.description.abstractCardiovascular diseases (CVD) are one of the major health problems worldwide and it accounts for one-third of all deaths. It is alarming that, India stands the highest in world for the CVD mortality and occurring in younger age groups thus resulting in tremendous loss of productive working years. Current therapy of heart failure is restricted to pharmacological and for patients with end-stage heart failure treatment options are extremely limited. Therefore, it is essential to develop more effective, less invasive therapeutic strategies. As the self-renewal capacity of adult cardiomyocytes is limited, the development of strategies to regenerate damaged myocardium and improve heart function represents a major challenge. Transplantation of various precursor cells have been attempted for myocardial regeneration, including adult cardiac myocytes, skeletal muscle stem cell, autologous bone marrow stem cells (BMC), immobilized peripheral blood stem cells, embryonic stem cells (ESCs) and mesenchymal stem cells (MSCs). The potential ability of bone marrow derived mesenchymal stem cells (BMSC) to transdifferentiate into cardiomyocytes both in vitro and in vivo are currently being explored for cellular cardiomyoplasty. It has been shown that the methods adopted for isolation, characterization, ex vivo expansion of BMSC and the existing protocols for efficient induction of cardiomyogenic differentiation remain inconsistent. Moreover, the use of BMSCs in cell based therapeutic strategies requires a large number of ex vivo expanded cells that maintain their multilineage differentiation potential under animal serum free conditions are essential. Therefore there is a need to improve the current methods of isolation, characterization, ex vivo expansion and develop protocol for efficient cardiomyogenic differentiation of BMSC. Hence the present study was undertaken to isolate, characterize the BMSCs and evaluate their cardiomyogenic differentiation in animal serum free conditions. The present thesis comprises of five chapters.en_US
dc.titleCharacterization ex vivo expansion and cardiomyogenic differentiation of human bone marrow derived mesenchymal stem cellsen_US
dc.creator.researcherBaraneedharan Uen_US
dc.subject.keywordHuman bone marrowen_US
dc.subject.keywordMesenchymal stem cellsen_US
dc.description.noteSummary p. 122-123, Reference p. 1-174 Annexures p. 124-126en_US
dc.contributor.guideVenkatachalam Pen_US
dc.publisher.universitySri Ramachandra Universityen_US
dc.publisher.institutionCollege of Biomedical Sciencesen_US
Appears in Departments:College of Biomedical Sciences

Files in This Item:
File Description SizeFormat 
10_chapter 1.pdfAttached File564.04 kBAdobe PDFView/Open
11_chapter 2.pdf239.24 kBAdobe PDFView/Open
12_chapter 3.pdf1.28 MBAdobe PDFView/Open
13_chapter 4.pdf506.9 kBAdobe PDFView/Open
14_chapter 5.pdf1.14 MBAdobe PDFView/Open
15_summary and conclusions.pdf80.4 kBAdobe PDFView/Open
16_annexures.pdf337.07 kBAdobe PDFView/Open
01_title.pdf129.55 kBAdobe PDFView/Open
02_declaration.pdf114.03 kBAdobe PDFView/Open
03_certificate.pdf113.28 kBAdobe PDFView/Open
04_acknowledgements.pdf60.91 kBAdobe PDFView/Open
05_contents.pdf112.81 kBAdobe PDFView/Open
06_abbreviations.pdf134.36 kBAdobe PDFView/Open
07_list of figures.pdf61.11 kBAdobe PDFView/Open
08_list of tables.pdf57.03 kBAdobe PDFView/Open
09_abstract.pdf131.26 kBAdobe PDFView/Open
17_reference.pdf143.19 kBAdobe PDFView/Open

Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: